Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of PTC Therapeutics Inc (NASDAQ: PTCT) was $46.75 for the day, up 0.78% from the previous closing price of $46.39. In other words, the price has increased by $0.78 from its previous closing price. On the day, 1.24 million shares were traded. PTCT stock price reached its highest trading level at $47.48 during the session, while it also had its lowest trading level at $45.8.
Ratios:
Our analysis of PTCT’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.35. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 3.89.
On May 07, 2025, Citigroup Upgraded its rating to Neutral which previously was Sell but kept the price unchanged to $40.
BofA Securities Upgraded its Underperform to Neutral on March 11, 2025, whereas the target price for the stock was revised from $41 to $55.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 22 ’25 when Klein Matthew B. sold 2,804 shares for $48.74 per share. The transaction valued at 136,656 led to the insider holds 273,234 shares of the business.
Klein Matthew B. bought 2,804 shares of PTCT for $136,656 on Apr 22 ’25. On Apr 02 ’25, another insider, Golden Lee Scott, who serves as the EVP & CHIEF MEDICAL OFFICER of the company, sold 897 shares for $46.95 each. As a result, the insider received 42,114 and left with 75,997 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTCT now has a Market Capitalization of 3705264640 and an Enterprise Value of 4155525632. As of this moment, PTC’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.18. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.09. Its current Enterprise Value per Revenue stands at 2.344 whereas that against EBITDA is 4.639.
Stock Price History:
The Beta on a monthly basis for PTCT is 0.49, which has changed by 0.37378788 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, PTCT has reached a high of $58.38, while it has fallen to a 52-week low of $28.72. The 50-Day Moving Average of the stock is -4.68%, while the 200-Day Moving Average is calculated to be 7.81%.
Shares Statistics:
PTCT traded an average of 1.17M shares per day over the past three months and 2170730 shares per day over the past ten days. A total of 79.23M shares are outstanding, with a floating share count of 77.20M. Insiders hold about 2.60% of the company’s shares, while institutions hold 100.50% stake in the company. Shares short for PTCT as of 1745971200 were 5006670 with a Short Ratio of 4.26, compared to 1743379200 on 5418328. Therefore, it implies a Short% of Shares Outstanding of 5006670 and a Short% of Float of 7.26.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
